Rondo Therapeutics is developing bispecific antibody drugs capable of treating solid tumors, which have eluded this type of cancer therapy. Led by co-founders and Teneobio veterans Shelley Force Aldred and Nathan Trinklein, the biotech startup has emerged from stealth backed by a $67 million Series A round of funding.
By Michael McAuliff, Kaiser Health News Friday, March 4, 2022 7:05 PM
The idea of helping millions of Americans with diabetes afford a crucial medicine has immense public support and even bipartisan adherents. But then, there is politics — between Democrats and Republicans, of course, but also among Democrats.
Anti-infective drug discovery startup ArrePath has launched with $20 million in seed funding to advance the development of molecules that use a dual mechanism to kill bacteria. The Princeton University spinout says its approach could overcome the drug resistance bacteria are developing to currently available products.
A judge ruled the lawsuit against Eli Lilly for their Medicaid rebate payments will proceed to trial; Ely Lilly is accused of underpaying for Medicaid rebates between 2005 and 2016.
By Elizabeth Marshall Friday, March 4, 2022 11:06 AM
To reduce time-consuming manual searches and improve their findings, many organizations are turning to artificial intelligence technologies such as natural language processing. Clinical and research institutions are adopting NLP to capture unstructured information from EHRs that helps with diagnosis.
MedCity INVEST 2022 at The Ritz Carlton Chicago is a 3 day gathering with numerous opportunities for in-person networking and learning around the latest technologies and investment trends from VCs and successful entrepreneurs.
.png?width=200&height=166&upscale=true&name=MedCity_News%20(1).png)
No comments